NCT02080143终止不适用
A Randomized, Open-Label, Comparative Study To Evaluate the Adhesion and Temperature Properties of Two Air-Activated, Adhesive Backed Heat Patches in Healthy Volunteers
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 200
- 试验地点
- 2
- 主要终点
- Heat Intensity
研究概览
简要总结
A disposable, air-activated, adhesive backed heat patch is being evaluated.
Study terminated -O subjects.
详细描述
Study Protocol Terminated--0 subjects
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Subjects who complete an appropriately administered informed consent process that includes signing the IRB-approved consent form;
- •subjects 18-75 years old of each sex;
- •are of any skin type or race, providing the skin pigmentation will allow discernment of erythema;
- •subjects who are in good general health and free of any disease state or physical condition;
- •subjects who are willing and able to have the study products applied as directed, and comply with study instructions;
- •subjects must be willing to restrict their activity for the 8 hour patch wear time so that patches and thermocouples do not come loose;
- •subjects must be willing to wear a pouch containing the thermologger and thermocouple wiring for the entire 8 hours;
- •subjects who are 55 years or older agree to wear a t-shirt provided by the site for the entire 8 hour patch wear time.
排除标准
- •Subjects who are pregnant or nursing;
- •subjects with excessive hair at the application site, scar tissue, tattoo or coloration that would interfere with the placement of the study product or the skin assessment;
- •subjects with diabetes or poor circulation or have any clinically significant chronic illness which could place the subject at increased risk during participation or result in inappropriate dermal response during the study;
- •subjects unable to feel pain or heat (e.g., subjects with neuropathy);
- •subjects with active dermatitis (including sunburn) in the treatment area or other visible dermatological disease which, in the investigator's opinion, might interfere with the response to the study products or interfere with the skin assessments associated with the study products;
- •have history of significant dermatologic cancers or neoplasms in the treatment area;
- •subjects who have used topical dermatological products in the application area within 24 hours prior to anticipated study product application;
- •subjects using a concomitant medication that, in the investigator's opinion, could interfere with the interpretation of the study results. Examples of such drugs include vasoactive (constrictor or dilator) medications, prescription or OTC, that could modulate blood flow, within 24 hours prior to or during the application of study products, including nitroglycerin, non-steroidal anti-inflammatory products (NSAIDs, e.g., ibuprofen, aspirin (<=81 mg/day is acceptable)), topical corticosteroids and OTC cough/cold products including antihistamines and/or either phenylpropanolamine or phentolamine;
- •subjects who have used systemic steroids (i.e., oral, IV, IM or intra-articular) 30 days prior to the application of test articles (intranasal/inhaled steroids are acceptable);
- •subjects who have received an investigational medication or device within 30 days prior to enrollment into this study;
- •subjects who have a history of sensitivity to any of the study products or adhesion materials;
- •subjects who are currently participating in an investigational study;
- •subjects who are known to be noncompliant or are unlikely to comply with the requirements of the study protocol (e.g., due to alcoholism, product dependency, mental incapacity) in the opinion of the investigator.
结局指标
主要结局
Heat Intensity
时间窗: 8 hours
Assessed using sensors.
次要结局
- Adhesion Evaluation(8 hours)
- Irritation Evaluation(8 hours)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Evaluation of Experimental Heat PatchEffects of HeatTolerabilityAdhesivenessDermal IrritationNCT01841788Chattem, Inc.40
已完成
2 期
Fibrin Sealant VH S/D 500 S-apr in Hepatic ResectionBleeding (Oozing) in Hepatic ResectionNCT01244425Baxter Healthcare Corporation70
已完成
不适用
Treatment of Wounds With a New Adhesive Foam DressingWounds and InjuriesBurnsNCT02807584Smith & Nephew, Inc.25
终止
2 期
Topical Composition Therapy for the Treatment of Cutaneous MastocytosisCutaneous MastocytosesNCT04846348Joseph Butterfield1
已完成
1 期
Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Generic Lidocaine Patch 5% in Healthy, Adult, Human SubjectsHealthyNCT04319926Scilex Pharmaceuticals, Inc.24